143 Odcinki

  1. Immunotherapy rechallenge in NSCLC

    Opublikowany: 3.03.2022
  2. ESO’s career development programme

    Opublikowany: 24.02.2022
  3. Summary/Review - Reporting Guidelines - CONSORT

    Opublikowany: 17.02.2022
  4. Summary/Review: Long-term results of SNB after NCT for primary cN1/2 breast who convert to cN0

    Opublikowany: 10.02.2022
  5. Summary/Review: Pathology after neoadjuvant treatment for breast cancer – How to assess residual disease.

    Opublikowany: 3.02.2022
  6. Intraoperative breast ultrasound

    Opublikowany: 27.01.2022
  7. Summary/Review - Reporting Guidelines - PRISMA 2020

    Opublikowany: 20.01.2022
  8. Summary/Review - The use of Artificial Intelligence in the Oncology field. Addressing all the hype and skepticism.

    Opublikowany: 13.01.2022
  9. Advanced Gastric Cancer

    Opublikowany: 9.12.2021
  10. PARP inhibitors for the treatment of ovarian cancer

    Opublikowany: 2.12.2021
  11. The role of clinician-scientists in modern oncology

    Opublikowany: 25.11.2021
  12. Pharmacologic interactions with new drugs

    Opublikowany: 18.11.2021
  13. Positive Resection Margins in Colon Cancer

    Opublikowany: 11.11.2021
  14. Immunotherapy in Lung Cancer

    Opublikowany: 4.11.2021
  15. Low HR positive breast cancer

    Opublikowany: 28.10.2021
  16. Possibilities of tackling side effects of cancer therapies

    Opublikowany: 21.10.2021
  17. Fertility preservation in young cancer patients

    Opublikowany: 14.10.2021
  18. CDK4/6i in HR+HER2- breast cancer

    Opublikowany: 7.10.2021
  19. Treatment selection in castration-resistant prostate cancer

    Opublikowany: 30.09.2021
  20. Questions and Controversies in Localized Head and Neck Cancer

    Opublikowany: 23.09.2021

6 / 8

e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net

Visit the podcast's native language site